TheThe 1st1st BioForumBioForum HangzhouHangzhou BayBay ·Ningbo·Ningbo Nov.11 – 13th, 2016 | Bay· NingboNingbo ·· ChinaChina Nov. 11-13, 2016 Get to know the latest biopharmaceutical policy and access the world of opportunities & challenges with life science insiders

As one of 's “Seven Strategic Emerging Industries”, the biopharmaceutical industry has obtained vigorous support from the central government to local governments at all levels, and it’s also a key development domain in Ningbo. With the guidance of various policy documents and the agglomeration of production factors, biopharmaceutical industry in Ningbo has entered the fast lane. Held on Nov. 11th to 13th, the 1st BioForum Hangzhou Bay Ningbo aims to help our peers get a better understand of the new drug policy, facilitate new drug R&D and traditional drug firms achieve faster innovative development, etc. Hosted by Chinese Pharmaceutical Enterprise Association and Administrative Committee of Ningbo , this forum will be organized by Biovillage and Research Institute of Fudan University in Ningbo. CFDA officers, industry research experts, innovative drug R&D experts, renowned drug firms’ executives and well-known investors from bio-pharmaceutical area have been invited to attend the forum. Also more than 300 biopharmaceutical researchers, administrators, investors, and consultants will join in the forum. In this beautiful autumn, let’s get together at the shore of Hangzhou Bay and the south side of Hangzhou Bay Seakross Bridge; hear key biotech and pharma leaders discuss the latest industry trends in workshops and panels.

【Highlights】 Subjects: Drug R&D and innovation under new drug policy Date : 11th – 13th Nov. 2016 Venue : Empark Grand Hotel, Hangzhou Bay New Zone, Ningbo Address: No. 9, Jinyuan Avenue, Hangzhou Bay, Ningbo

The 1st BioForum Hangzhou Bay Ningbo 【Speakers】 （updating）

Zhenjia Bian Thomas McCoy Roberts, Ph.D. Mingde Yu, Ph.D. Special Researcher, Counsellors' Professor of Biological Chemistry Honorary President of Chinese Office of the State Council & Molecular Pharmacology, Pharmaceutical Enterprise Association Former Deputy Director of CFDA Harvard Medical School

Mingwei Wang, Prf. Jean Zhao, Ph.D. Xiang Gao, Ph.D. Dean of School of Pharmacy, Professor of Biological Chemistry Director & Founder of Nanjing Fudan University &Molecular Pharmacology, Biomedical Research Institute of Harvard Medical School Nanjing University President of NRCMM

Ruiping Dong M.D., Ph.D. Shixin Jiang Hua Yang, Ph.D. CEO, RMX Pharma Chairman & President of Rundo CSO of Pharmaron Former SVP & Head of Emerging International Pharmaceutical Research Markets R&D, Merck & Co & Development Co., Ltd President of CROU

The 1st BioForum Hangzhou Bay Ningbo Steven Wang, CFA Zhengyang Wang, Attorney Jufeng Wang, Ph.D. Managing & Founding Partner Attorney, Senior Partner Junzejun SVP of Pharmaron HighLight Capital Law Offices () Former Director of National Center for Safety Evaluation of Drugs, China

Qing Zhou, MD, Ph.D. Feng Zhou, Ph.D. Sirui Li CSO of Genor Biopharma Product & Solution Specialist of IP & General Manager of Strategic Science business, Thomson Reuters Development Department, Tasly Pharm

Guozhong Rui Juan Du, Ph.D. Pengjun Sun, Ph.D. Chairman of CPTTC Director, HUYA Bioscience Executive Dean, International, Shanghai Office Research Institute of Fudan University in Ningbo

The 1st BioForum Hangzhou Bay Ningbo 【Organization Entities】 Hosts: Chinese Pharmaceutical Enterprises Management Association, Administrative Committee of Ningbo Hangzhou Bay New Zone Organizers: Biovillage, Research Institute of Fudan University in Ningbo Co-organizers: BioClub, SAPA, SABPA, CABS Funding agencies (updating):

●Diamond Sponsor ——

●Platinum Sponsor ——

●Golden Sponsor ——

Supporters and media: Ningbo Association for Science and Technology, Jietong Group, Healthcare Executive, Biodiscover, New Drug Investors Club, Shanghai Medicine Service Platfrom, Bioon, Gaochuanghui, Western Biotechnology Inc, Translational Medicine Network, Founder Club of New Drugs, Medicine Economic Reporter, Progress in Pharmaceutical Sciences, Vcbeat

【Topics】 ●Interpretation of new drug policy and industrial analysis — Challenges, opportunities, status and trends ●Drug R&D--Innovation and collaboration ●Biopharmaceutical CRO — New trends and growth in China ●Biomedical investment and financing — Venture capital and acquisition

The 1st BioForum Hangzhou Bay Ningbo 【Agenda】

4U\ ͹͹ 8KMOYZXGZOUT 4U\    8KMOYZXGZOUT 4KZ]UXQOTM 2IILFLDO RI WKH $GPLQLVWUDWLYH &RPPLWWHH 2SHQLQJ 5HPDUN 7%1 RI +DQJ]KRX %D\ 1HZ =RQH    2IILFLDO RI WKH &KLQHVH 2SHQLQJ 5HPDUN 7%1 3KDUPDFHXWLFDO (QWHUSULVH $VVRFLDWLRQ 2SHQLQJ 5HPDUN 7%1 =-)'$ 2IILFLDO /LIH +HDOWK ,QGXVWU\ LQ 1LQJER +DQJ]KRX 'HSXW\ 'LUHFWRU RI ,QYHVWPHQW 3URPRWLRQ    %D\ 1HZ =RQH DQG WKH +XL =KDQJ DQG &RRSHUDWLRQ %XUHDX RI 1LQJER 5HODWHG 3URPRWLRQ +DQJ]KRX %D\ 1HZ =RQH SROLFLHV 9KYYOUT Ɉ /TZKXVXKZGZOUT UL 4K] *X[M 6UROI_ GTJ /TJ[YZXOGR 'TGR_YOY ȉ )NGRRKTMKY 5VVUXZ[TOZOKY 9ZGZ[Y GTJ :XKTJY 9KYYOUT )NGOX͵ 0[LKTM =GTM 6N*  9<6 UL 6NGXSGXUT 6SHFLDO 5HVHDUFKHU &RXQVHOORUV 2IILFH 'UXJ ,QQRYDWLRQ LQ   =KHQMLD %LDQ RI WKH 6WDWH &RXQFLO)RUPHU 'HSXW\ &KLQD 'LUHFWRU &)'$ 7KH &XUUHQW 3KDUPDFHXWLFDO +RQRUDU\ 3UHVLGHQW RI &KLQHVH   0LQJGH

   2[TIN (XKGQ

The 1st BioForum Hangzhou Bay Ningbo 9KYYOUT Ɋ *X[M 8 * ȉȉ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ɋ (OUSKJOIGR /T\KYZSKTZ GTJ ,OTGTIOTM ȉ

4U\

   -GOT ZNK /TYOMNZ UL .GTM`NU[ (G_ 4K] @UTK

   2[TIN

ЈԠ *KVGXZ[XK

The 1st BioForum Hangzhou Bay Ningbo 【Attendees】 Executives of pharmaceutical enterprises Founder and executives of innovative drug firms BDs and technical directors in pharmaceutical enterprises Biomedical venture capital executives Specialists of medical policy Industry research analysts Scholars and experts from universities and academic institutions

【Registration】 Ms Ella [email protected] 13857885089

【About the Hosts】 Chinese Pharmaceutical Enterprise Association Chinese Pharmaceutical Enterprise Association was established in July 1985, registered in the People's Republic of China Ministry of Civil Affairs. It is a national, non-profit social organization. Chinese Pharmaceutical Enterprise Association is led by State – owned Assets Supervision and Administration Commission of the State Council. The purpose and the general objectives of the association are: publicity and implementation of the party's principles and policies; to serve pharmaceutical enterprises and pharmaceutical entrepreneurs (managers); promoting the modernization of enterprise management and production technology modernization; building a bridge between the government and enterprises, exploring and establishing a modern enterprise system and in line with the socialist market economic law of Chinese pharmaceutical enterprise management system. Administrative Committee of Ningbo Hangzhou Bay New Zone Ningbo Hangzhou Bay New Zone is located in the north of Ningbo, southern bank Hangzhou Bay Seakross Bridge. It is in the geometric center

The 1st BioForum Hangzhou Bay Ningbo of Shanghai, Hangzhou and Ningbo, within 2-hour economic circle of the three cities. The new zone is a state-level economic and technological development zone in the Yangtze River Delta region. Since the establishment of the new zone, GDP, gross industrial output value, total social fixed asset investment, fiscal revenue and other major economic indicators have been keeping in growth of high speed with the annual average growth rate of 27.8%, 24.7%, 27.8% and 24.7% respectively. To 2015, the regional production value would exceed 35 billion yuan; gross industrial output value reach 150 billion yuan; the total social investment in fixed assets completed within three years exceed 80 billion yuan; total investment of introduced projects exceeds 80 billion yuan. In recent years, the biopharmaceutical industry has been developing rapidly with the related policies released by Ningbo municipal government and the government of Ningbo Hangzhou Bay New Zone, the agglomeration environment has been built up. Especially, BioVillage and Research Institute of Fudan University in Ningbo have landed here in the New Zone, and followed by the leading CRO Pharmaron, Ningbo Crimson Biotech, and Shuangchengmed,etc. We believe more biopharmaceutical companies will come in soon.

【About the Organizers】 BioVillage BioVillage is located in Ningbo Hangzhou Bay New Zone, southern bank of Hangzhou Bay Seakross Bridge. It covers 16.7 hectares area containing 250,00㎡ of buildings with various functions, which will be constructed including incubator, office buildings, state-of-the-art GMP pilot laboratory, cutting-edge test & analysis platform and SPF experimental animal facility, etc. The goal is to create a science park with garden style in an internationalized way. The total investment is RMB 5.6 billion. Fortunately, with Pharmaron and its drug R & D capability joining in the park, you will be offered with professional, internationalized, first-class

The 1st BioForum Hangzhou Bay Ningbo outsourcing service, which is undoubtedly save your cost and time dramatically in new drug R&D. Research Institute of Fudan University in Ningbo Research Institute of Fudan University in Ningbo is the only platform that offers political, industrial and research service in ; it is set up to focus on hi-tech talent innovation and industrialization of scientific and technological achievements. Such as bio medicine and medical market, green technology (new energy, new materials and energy saving & environmental protection), IT and technology culture. It also provides space, technical support and investment docking and other assistances. It committed to "diversify innovation, multi-level financial technology, professional research service”, to build a sound ecological system and innovation, professional and international platform for innovation and entrepreneurship.

The 1st BioForum Hangzhou Bay Ningbo